Coburn Bryan, Li Yuling, Owen David, Vallance Bruce A, Finlay B Brett
Michael Smith Laboratories, University of British Columbia, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada.
Infect Immun. 2005 Jun;73(6):3219-27. doi: 10.1128/IAI.73.6.3219-3227.2005.
Salmonella species cause a wide range of disease in multiple hosts. Salmonella enterica serovar Typhimurium causes self-limited intestinal disease in humans and systemic typhoid-like illness in susceptible mice. The prevailing dogma in murine S. enterica serovar Typhimurium pathogenesis is that distinct virulence mechanisms-Salmonella pathogenicity islands 1 and 2 (SPI1 and SPI2)-perform distinct roles in pathogenesis, the former being important for invasion and intestinal disease and the latter important for intracellular survival and systemic persistence and disease. Although evidence from bovine infections has suggested that SPI2 has a role in ileal disease, there is no evidence that SPI2 is important for inflammation in a disease that more closely recapitulates human colitis. Using S. enterica serovar Typhimurium strains that lack functional type III secretion systems, we demonstrate that SPI2 is essential for complete virulence in murine infectious enterocolitis. Using a recently characterized murine model (M. Barthel,S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. Russmann, and W. D. Hardt, Infect. Immun. 71:2839-2858, 2003), we demonstrate that SPI1 mutants are unable to cause intestinal disease 48 h after infection and that SPI2-deficient bacteria also cause significantly attenuated typhlitis. We show that at the peak of inflammation in the cecum, SPI2 mutants induce diminished intercellular adhesion molecule 1 expression and neutrophil recruitment but that wild-type and mutant Salmonella are similarly distributed in the lumen of the infected organ. Finally, we demonstrate that attenuation of intestinal inflammation is accompanied by resolution of typhlitis in the mutant, but not wild-type, infections. Collectively, these results indicate that SPI2 is needed for enterocolitis, as well as for systemic disease.
沙门氏菌可在多种宿主中引发广泛的疾病。肠炎沙门氏菌鼠伤寒血清型可导致人类出现自限性肠道疾病,并在易感小鼠中引发全身性伤寒样疾病。关于鼠伤寒血清型肠炎沙门氏菌发病机制的主流观点认为,不同的毒力机制——沙门氏菌致病岛1和2(SPI1和SPI2)——在发病过程中发挥不同作用,前者对侵袭和肠道疾病很重要,后者对细胞内存活、全身持续性感染及疾病很重要。尽管来自牛感染的证据表明SPI2在回肠疾病中起作用,但没有证据表明SPI2在更类似于人类结肠炎的疾病的炎症中起重要作用。利用缺乏功能性III型分泌系统的肠炎沙门氏菌鼠伤寒血清型菌株,我们证明SPI2对鼠传染性小肠结肠炎的完全毒力至关重要。利用最近描述的一种小鼠模型(M. Barthel、S. Hapfelmeier、L. Quintanilla-Martinez、M. Kremer、M. Rohde、M. Hogardt、K. Pfeffer、H. Russmann和W. D. Hardt,《感染与免疫》71:2839 - 2858,2003),我们证明SPI1突变体在感染48小时后无法引发肠道疾病,且SPI2缺陷型细菌也会导致盲肠炎明显减轻。我们发现,在盲肠炎症高峰期,SPI2突变体诱导细胞间黏附分子1表达减少和中性粒细胞募集减少,但野生型和突变型沙门氏菌在受感染器官腔内的分布相似。最后,我们证明肠道炎症的减轻伴随着突变体而非野生型感染中盲肠炎的消退。总体而言,这些结果表明SPI2对小肠结肠炎以及全身性疾病都是必需的。